Review: The delivery of ivermectin (Mectizan®)

Tropical Medicine and International Health

Volumn 9, Issue 4, 2004, Pages

  Burnham, G ^a   Mebrahtu, T ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Health systems; Ivermectin; Loa loa; Mass treatment; Mectizan; Onchocerciasis; Public private partnership

Indexed keywords

IVERMECTIN; ANTIFILARIAL AGENT;

DISEASE CONTROL; IVERMECTIN; ONCHOCERCIASIS; PUBLIC-PRIVATE PARTNERSHIP;

AFRICA; COMMUNITY CARE; DISEASE CONTROL; DRUG COST; DRUG MARKETING; DRUG MONITORING; ENDEMIC DISEASE; FUTUROLOGY; GOVERNMENT; HEALTH CARE FACILITY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INFECTION CONTROL; ONCHOCERCIASIS; ORGANIZATION; POPULATION RESEARCH; PROFESSIONAL PRACTICE; PUBLIC HEALTH SERVICE; REVIEW; SEX DIFFERENCE; TECHNIQUE; WESTERN HEMISPHERE; DEVELOPING COUNTRY; HEALTH CARE QUALITY; INTERNATIONAL COOPERATION;

LOA LOA; ONCHOCERCA; ONCHOCERCA VOLVULUS;

DEVELOPING COUNTRIES; FILARICIDES; HUMANS; INTERNATIONAL COOPERATION; IVERMECTIN; ONCHOCERCIASIS; PROGRAM EVALUATION;

EID: 3042596028     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2004.01211.x     Document Type: Review

References (88)

1. Akogun OB, Akogun MK & Audu Z (2000) Community perceived benefits of ivermectin treatment in northeastern Nigeria. Social Science and Medicine 50, 1451-1456.
2. Alley SA, van Oortmarssen GGJ, Boatin BBA et al. (2001) Macrofilaricides and onchocerciasis control, mathematical modeling of the prospects for elimination. BMC Public Health 1, 12.
3. Amazigo U, Noma M, Boatin BA, Etya'alé DE, Séké téle A & Dadzie KY (1998) Delivery systems and cost recovery in Mectizan treatment for onchocerciasis. Annals of Tropical Medicine and Parasitology 92, S23-S31.
4. Amazigo U, Brieger WR, Katabarwa M et al. (2002) The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC). Annals of Tropical Medicine and Parasitology 96, S41-S58.
5. APOC (1998) Community-Directed Treatment with Ivermectin (CDTI). A Practical Guide for Trainers of Community-Directed Distributors. APOC, Ouagadougou.
6. APOC (2000a) Programme Implementation 2. APOC, Ouagadougou.
7. APOC (2000b) Report of the Mid-term (Phase I) External Evaluation of APOC. APOC, Ouagadougou.
8. APOC (2000c) Monitoring CDTI Projects - Adequacy of Procedures and Application of Outcomes. APOC, Ouagadougou.
9. APOC (2001) Programme Document for Phase II (2002-2007) and the Phasing out Period (2008-2010). WHO, Geneva.
10. APOC (2002a) Report of the Second Meeting of National Onchocerciasis Task Forces, June 2002. APOC, Ouagadougou.
11. APOC (2002b) Monitoring CDTI Projects: Adequacy of Procedures and Applications of Outcomes. APOC, Ouagadougou.
12. APOC (2002c) Sustainability Evaluation Instrument no. 3 - First Line Health Facility Level. APOC, Ouagadougou.
13. APOC (2002d) Sustainability Evaluation Instrument no. 2 - District/LGA Level. APOC, Ouagadougou.
14. APOC (2002e) Guidelines for Conducting a Sustainability Evaluation of an APOC Project. APOC, Ouagadougou.
15. Benton B, Bump J, Sékétéli A & Liese B (2002) Partnership and promise: evolution of the African river-blindness campaigns. Annals of Tropical Medicine and Parasitology 96, S75-S14.
16. Blanks J, Richards F, Beltran F et al. (1998) The onchocerciasis elimination programme for the Americas: a history of partnership. Pan American Journal of Public Health 3, 367-374.
17. Boussinesq M, Gardon J, Kamgno J, Pion SD, Gardon-Wendel N & Chippaux JP (2001) Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon. Annals of Tropical Medicine and Parasitology 95, 495-507.
18. Brieger WR, Otusanya SA, Oke GA, Oshiname FO & Adeniyi JD (2001) Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State Nigeria. Tropical Medicine and International Health 7, 11-18.
19. Brown KR (1998) Changes in the use profile of Mectizan 1987-1997. Annals of Tropical Medicine and Parasitology 92, S61-S64.
20. Carter Center (2002) Final Report of the Conference on the Eradicability of Onchocerciasis. Carter Center, Atlanta.
21. Clemmons L, Amazigo UV, Bissek A-C et al. (2002) Gender issues in the community-directed treatment with ivermectin (CDTI) of the African Programme for Onchocerciasis Control. Annals of Tropical Medicine and Parasitology 96, S59-S74.
22. Collins RC, Gonzales-Peralta C, Castro J et al. (1992) Ivermectin: reduction in prevalence and infection intensity with Onchocerca volvulus following biannual treatment in five Guatemalan communities. American Journal of Tropical Medicine and Hygiene 47, 156-169.
23. Cross C (2000) Elimination of lymphatic filariasis as a public health problem. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 601-602.
24. Cupp EW, Ochoa JO, Collins RC et al. (1992) The effects of repetitive community-wide ivermectin treatment of transmission of Onchocerca volvulus in Guatemala. American Journal of Tropical Medicine and Hygiene 47, 170-180.
25. Dadzie KY, Remme J, de Sole G et al. (1991) Onchocerciasis control by large-scale ivermectin treatment. Lancet 337, 1358-1359.
26. Davies JB (2002) Predication of feasibility of onchocerciasis eradication. In: Final Report of the Conference of the Eradicability of Onchocerciasis (eds Y Dadzie, DR Hopkins, M Neira). Carter Center, Atlanta, pp. 79-80.
27. Dent JA, Smith McH M, Vassilantis DK & Avery L (2000) The genetics of ivermectin resistance in Caenorhabditis elegans. Proceedings of the National Academy of Sciences of the United States of America 97, 2674-2679.
28. Drameh PS, Richards FO, Cross C, Etya'alé DE & Kassalow JS (2002) Ten years of NGDO action against river blindness. Trends in Parasitology 18, 378-380.
29. Fettig CT (1998) The donation of Mecitzan. Annals of Tropical Medicine and Parasitology 92, S161-S162.
30. Foege WH (1998) 10 years of Mectizan. Annals of Tropical Medicine and Parasitology 92, S7-S10.
31. Frost L, Reich MR & Fujisaki T (2002) A partnership for ivermectin: social worlds and boundary objects. In: Public-Private Partnerships for Public Health (ed. MR Reich) Harvard University Press, Cambridge, pp. 87-113.
32. Gardon J, Mace JM, Cadot E, Ogil C, Godin C & Boussinesq M (1996) Ivermectin-based control of onchocerciasis in northern Cameroon: individual factors influencing participation in community treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 218-222.
33. Godin C (1998) Cameroon and Chad: cost recovery. Annals of Tropical Medicine and Parasitology 92, S163-164.
34. Guderian RH, Anselmi M, Espinel M et al. (1997) Successful control of onchocerciasis with community-based ivermectin distribution in the Rio Santiago focus in Ecuador. Tropical Medicine and International Health 2, 982-988.
35. Gyapong M, Gyapong JO & Owusu-Banahene G (2001) Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana. Annals of Tropical Medicine and Parasitology 95, 77-86.
36. Hoerauf A, Mand S, Adjei O, Fleischer B & Büttner DW (2001) Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357, 1415-1416.
37. Homeida MMA, Goepp I, Magdi A, Hilyer E & Mackenzie CD (1999) Medical achievements under civil war conditions. Lancet 354, 601.
38. Homeida M, Braide E, El-Hassan E et al. (2002) APOCs strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. Annals of Tropical Medicine and Parasitology 96, S93-S104.
39. Katabarwa MN & Richards FO (2001) Community directed health (CDH) workers enhance the performance and sustainability of CDH programmes: experience from ivermectin distribution in Uganda. Annals of Tropical Medicine and Parasitology 95, 275-286.
40. Katabarwa M, Mutabazi D & Richards F (1999) The community-directed ivermectin-treatment for onchocerciasis control in Uganda - an evaluative study (1993-1997). Annals of Tropical Medicine and Parasitology 93, 727-735.
41. Katabarwa NM, Richards FO & Ndyomugyenyi R (2000a) In rural Ugandan communities the traditional kinship/clan is vital to the success and sustainment of the African Programme for Onchocerciasis Control. Annals of Tropical Medicine and Parasitology 94, 485-495.
42. Katabarwa NM, Mutabazi D & Richards FO (2000b) Controlling onchocerciasis by community-directed, ivermectin treatment programmes in Uganda: why do some communities succeed and others fail? Annals of Tropical Medicine and Parasitology 94, 343-352.
43. Katabarwa MN, Habomugisha P, Ndyomugyenyi R & Agunyo S (2001) Involvement of women in community-directed treatment with ivermectin for the control of onchocerciasis in Rukungiri district, Uganda: a knowledge, attitude and practice study. Annals of Tropical Medicine and Parasitology 95, 485-494.
44. Katabarwa MN, Habomugisha P & Richards FO (2002) Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997-2000): an evaluation. Annals of Tropical Medicine and Parasitology 96, 61-73.
45. Kipp W, Burnham G, Bamuhiiga J, Weis P & Büttner DW (1998) Ivermectin distribution using community volunteers in Kabarole district, Uganda. Health Policy and Planning 13, 167-173.
46. Martin-Tellaeche A, Ramirez-Hernandez J, Santos-Preciado JI & Mendez-Galvan J (1998) Onchocerciasis: changes in transmission in Mexico. Annals of Tropical Medicine and Parasitology 92, S117-S119.
47. Mectizan Donation Program (1999) Mectizan Treatment in Areas where Loaisis and Onchocerciasis are Co-endemic. MDP, Atlanta.
48. Mectizan Donation Program (2001) Mectizan Treatment in Areas where Loiasis and onchocerciasis are Co-endemic. Available at: http://65.208.79.90/ MDP. Accessed on 31 December 2002.
49. Ndyomugyenyi R & Remme J (2002) Using ivermectin-treatment coverage among schoolchildren monitored by schoolteachers as a proxy of population coverage in areas of Uganda where onchocerciasis is endemic. Annals of Tropical Medicine and Parasitology 96, 53-60.
50. Ngoumou P & Walsh JF (1993) A Manual for Rapid Epidemiological Mapping of Onchocerciasis. TDR/TDE/ONCHO/93.4. WHO, Geneva.
51. Ngoumou P, Walsh JF & Mace JM (1994) A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Annals of Tropical Medicine and Parasitology 88, 463-474.
52. Noma M, Nwoke BEB, Nutall I et al. (2002) Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control. Annals of Tropical Medicine and Parasitology 96, S29-39.
53. Nyiama T (1998) Community perspectives on Mectizans role as a catalyst for the formation of novel partnerships. Annals of Tropical Medicine and Parasitology 92, S169-S170.
54. Okwero P (1998) The challenge of establishing community-directed treatment with Mectizan in Uganda. Annals of Tropical Medicine and Parasitology 92, S171-S174.
55. Onwujekwe OE, Shu EN, Nwagbo D, Akpala CO & Okonkwo PO (1998) Willingness to pay for community-based ivermectin distribution: a study of three onchocerciasis-endemic communities in Nigeria. Tropical Medicine and International Health 10, 802-808.
56. Onwujekwe OE, Shu EN, Ndum CC & Okonkwo PO (2000a) Treatment with ivermectin: what works in one community may not work in another. Journal of Epidemiology and Community Health 54, 79-80.
57. Onwujekwe OE, Shu EN & Okonkwo PO (2000b) Community-financing of local ivermectin distribution in Nigeria: potential payment and cost-recovery outlook. Tropical Doctor 30, 91-94.
58. Oyibo WA & Fagbenro-Beyiku AF (1998) Evaluation of community compliance with annual ivermectin treatment of onchocerciasis in Patigi, Nigeria. East African Medical Journal 75, 237-242.
59. Patterson DK (1978) River blindness in Northern Ghana, 1900-50. In: Disease in African History (eds Hartwig GW & Patterson DK) Duke University Press, Durham, NC. pp. 88-117.
60. Peters DH & Phillips T (2004) Mectizan Donation Program: evaluation of a public-private partnership (in this issue).
61. Prozesky D, Blitz J & Gibson R (2001) An Investigation into the Administrative Requirements of the African Programme for Onchocerciasis Control. University of Pretoria, Faculty of Health Sciences, Pretoria.
62. Remme J, de Sole G, Dadzie KY et al. (1990) Large scale ivermectin distribution and its epidemiological consequences. Acta Leidensia 59, 177-191.
63. Richards FO (2002) Achieving and sustaining high treatment coverage: experience of OEPA. In: Final Report of the Conference of the Eradicability of Onchocerciasis. Carter Center, Atlanta, pp. 103-105.
64. Richards FO, Klein RE, Gonzales-Peralta C et al. (1995) Knowledge, attitudes and practices during a community-level ivermectin distribution campaign in Guatemala. Health Policy and Planning 10, 404-414.
65. Sauerbrey M (2002) Impact of ivermectin treatment in OEPA Countries. In: Final Report of the Conference of the Eradicability of Onchocerciasis. Carter Center, Atlanta, pp. 58-59.
66. Schwartz EC, Renk J, Hopkins AD, Huss R & Foster A (1998) A method to determine the coverage of ivermectin distribution in onchocerciasis-control programmes. Annals of Tropical Medicine and Parasitology 92, 793-796.
67. Sékétéli A, Adeoye G, Eyamba A et al. (2002) The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Annals of Tropical Medicine and Parasitology 96, S15-S28.
68. Shu EN, Onwujekwe EO, Lokili P & Okonkwo PO (2000) A health club for a community school in south-eastern Nigeria: influence on adult perception of onchocerciasis and compliance with community-based ivermectin therapy. Tropical Medicine and International Health 5, 222-226.
69. St André AV, Blackwell NM, Hall LR et al. (2002) The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 295, 1892-1895.
70. Takougang I, Meremikwi M, Wandji S et al. (2002) Rapid assessment method for the prevalence and intensity of Loa loa infection. Bulletin of the WHO 80, 852-858.
71. Tarimo E (2000) Final Report on Sustainability of Community-directed Treatment of onchocerciasis with Ivermectin. APOC, Ouagadougou.
72. Taylor HR, Duke BOL & Muñoz B (1992) The selection of communities for treatment of onchocerciasis with ivermectin. Tropical Medicine and Parasitology 43, 267-270.
73. Waters H & Rehwinkel JA (2004) Economic evaluation of Mectizan distribution (in this issue).
74. WHO (1991) Strategies for Ivermectin Distribution Through Primary Health Care Systems. WHO/PBL/91.24. WHO, Geneva.
75. WHO (1995) Onchocerciasis and its Control. WHO Technical Report Series 852, WHO, Geneva.
76. WHO (1996) Onchocerciasis, progress toward elimination in the Americas. Weekly Epidemiological Record 71, 277-279.
77. WHO (1997) Report of the Tenth Meeting of the Non-governmental Development Organisations Coordination Group for Ivermectin Distribution. WHO/PBL/97.67. WHO, Geneva.
78. WHO (2001) Summary Report of the OCP/TDR Meeting on the Impact of Ivermectin on onchocerciasis Transmission. Document JPC22-JAF7/INF/DOC.2. WHO, Geneva.
79. WHO (2002a) Onchocerciasis (river blindness): report from the eleventh Inter-American conference on onchocerciasis, Mexico City. Weekly Epidemiological Record 77, 249-253.
80. WHO (2002b) Report of the Nineteenth Meeting of the Non-governmental Development Organisations Coordination Group for Onchocerciasis Control. WHO/PBL/02.86. WHO, Geneva.
81. WHO (2002c) World Health Report. WHO, Geneva.
82. WHO/OCP (2001) Progress Report January-October 2001. WHO/OCP, Ouagadougou.
83. WHO/OCP (2002a) External Evaluation 2002. OCP, Ouagadougou.
84. WHO/OCP (2002b) Onchocerciasis Control in Special Intervention Zones including Sierra Leone in the OCP Area. WHO/OCP, Ouagadougou.
85. WHO/TDR (1996) Community-directed Treatment with Ivermectin. TDR/AFR/RP/96.1. WHO, Geneva.
86. WHO/TDR (2000) Implementation and Sustainability of Community-Directed Treatment of Onchocerciasis with Ivermectin. TDR/IDE/RP/CDTI/00.1. WHO, Geneva.
87. WHO/TDR (2002) Guidelines for the Rapid Assessment of Loa loa. TDR/IDE/RAPLOA/02.1. WHO/TDR, Geneva.
88. Winnen M, Plaiser AP & Alley ES (2002) Can ivermectin mass treatment eliminate onchocerciasis? Bulletin of the World Health Organisation 80, 384-390.